Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aethlon Medical (NQ: AEMD )

2.080 USD +0.150 (+7.77%)
Streaming Delayed Price Updated: 8:46 AM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aethlon Medical

< Previous 1 2 3 4 5 6 Next >
Pre-Market Technical Scan on Medical Equipment Equities -- Senseonics, Aethlon Medical, CHF Solutions, and Second Sight Medical Products
From PR Newswire
Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that the United States Patent and Trademark Office has... 
From PR Newswire
Market Trends Toward New Normal in FTD Companies, Acuity Brands, MINDBODY, Actinium Pharmaceuticals, XG Technology, and Aethlon Medical — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FTD Companies, Inc.... 
From GlobeNewswire News Releases
Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Sabrina Martucci Johnson to its Board... 
From PR Newswire
Pre-market Technical Scan on Medical Equipment Equities -- Aethlon Medical, Neovasc, ReWalk Robotics, and Avinger
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on AEMD, NVCN, RWLK, and AVGR which is a click away at... 
From PR Newswire
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Charles ("Chuck") J. Fisher, Jr., MD as... 
From PR Newswire
Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Charles ("Chuck") J. Fisher, Jr., MD to... 
From PR Newswire
Aethlon Medical Announces Fiscal 2018 Second Quarter Results
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal second quarter ended September 30,... 
From PR Newswire
Medical Equipment Stock Performance Review -- Corindus Vascular Robotics, Aethlon Medical, Align Technology, and Avinger
From PR Newswire
Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the second quarter... 
From PR Newswire
Aethlon Medical Announces Large-Scale Production Collaboration
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has established a collaboration with iBio, Inc.... 
From PR Newswire
iBio Announces Manufacturing Collaboration with Aethlon Medical
iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the establishment of an agreement with Aethlon Medical,... 
From GlobeNewswire News Releases
Aethlon Medical to Present at the 2017 BIO Investor Forum
Aethlon Medical, Inc. (Nasdaq:AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that its Chairman and CEO, Jim Joyce, will be a featured... 
From PR Newswire
Aethlon Medical Announces Compliance With Nasdaq Listing Criteria
Aethlon Medical, Inc. (NASDAQ: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that Nasdaq has formally notified the Company that it has... 
From PR Newswire
Aethlon Medical Announces Pricing of $6 Million Public Offering
Aethlon Medical, Inc. (NASDAQ:AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announces the pricing of a public offering of an aggregate of 5,454,546... 
From PR Newswire
Aethlon Medical Receives National Cancer Institute Contract Award
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the... 
From PR Newswire
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access Pathway (EAP)... 
From PR Newswire
Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced that its Chairman and CEO, Jim Joyce, will be a featured... 
From PR Newswire
Aethlon Medical Announces Fiscal 2018 First Quarter Results
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal first quarter ended June 30, 2017. 
From PR Newswire
Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the first quarter... 
From PR Newswire
Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the United States Patent and Trademark Office has... 
From PR Newswire
Aethlon Medical Announces Fiscal 2017 Results
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2017. 
From PR Newswire
Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced it will issue financial results for the fiscal year ended... 
From PR Newswire
Aethlon Medical To Present Clinical Study Results at The BIO International Convention
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that Company Chairman and CEO, Jim Joyce will present at... 
From PR Newswire
Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced that James Joyce, CEO, will be presenting an overview of... 
From PR Newswire
Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced James Joyce, CEO, will be a featured presenter at the LD... 
From PR Newswire
Aethlon Medical Releases Shareholder Update
Aethlon Medical, Inc. (Nasdaq: AEMD), today released the following shareholder update authored by its Chairman and CEO, Jim Joyce. 
From PR Newswire
Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, disclosed today that an interview conducted with Company CEO Jim Joyce on... 
From PR Newswire
Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study
The Technology is a Candidate to Treat Emerging Bioterror and Pandemic Threats 
From PR Newswire
Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017
Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the ROTH Capital Partners 29th Annual Growth Stock Conference in Dana Point, CA at 10:30... 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.